ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection in pre-filled syringe - diphteria toxoid, adsorbed; poliomyelitis virus, inactivated; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

ベルギー - 英語 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

マルタ - 英語 - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - diphtheria toxoid, tetanus toxoid, bordetella pertussis, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate - powder for suspension for injection - diphtheria toxoid 30 iu tetanus toxoid 40 iu bordetella pertussis 30 iu pertussis toxoid 25 µg filamentous haemagglutinin (fha) 25 µg pertactin 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg - vaccines

イスラエル - 英語 - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - powder and suspension for suspension for injection - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - bordetella bronchiseptica; canine parainfluenza virus; aluminium hydroxide - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.05 ug/ml; canine parainfluenza virus vaccine-viral active 1000000.0 tci50/ml; aluminium hydroxide mineral-aluminium-base other 3.0 mg/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | canine parainfluenza | canine cough syndrome | infectious tracheobronchitis

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - bordetella bronchiseptica (inactivated cell free extract - parenteral liquid/solution/suspension - bordetella bronchiseptica (inactivated cell free extract vaccine-microbial active 7.5 ug/ml - immunotherapy - dog | bitch | castrate | puppy - bordetella bronchiseptica | kennel cough | canine cough syndrome | infectious tracheobronchitis

オーストラリア - 英語 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - bordetella bronchiseptica; canine parainfluenza virus; aluminium hydroxide - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.05 ug/ml; canine parainfluenza virus vaccine-viral active 1000000.0 tci50/ml; aluminium hydroxide mineral-aluminium-base other 3.0 mg/ml - immunotherapy - dog - with exclusions see label - bordetella spp. | canine parainfluenza | bordetella bronchiseptica

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct778 - bordetella ivds - for the in vitro qualitative detection and discrimination of bordetella pertussis and bordetella parapertussis in nasopharyngeal swabs (nps) from human patients with signs and symptoms of bacterial respiratory tract infection. for use on the 3m integrated cycler instrument.

イスラエル - 英語 - Ministry of Health

medici medical ltd, israel - diphtheria toxoid; filamentous haemagglutinin (fha); fimbrae tupes 2 + 3 (fim); pertactin; pertussis acellular; tetanus toxoid - suspension for injection - pertussis acellular 10 mcg / 0.5 ml; filamentous haemagglutinin (fha) 5 mcg / 0.5 ml; fimbrae tupes 2 + 3 (fim) 5 mcg / 0.5 ml; pertactin 3 mcg / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml - pertussis, purified antigen, combinations with toxoids - pertussis, purified antigen, combinations with toxoids - is indicated for the primary immunization of infants at or above the age of 2 months and as a booster in children up to their 6th birthday against diphtheria, tetanus and pertussis.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

diasorin australia pty ltd - ct778 - bordetella ivds - for the detection and quantitation of antibodies to bordetella pertussis and bordetella pertussis toxin in human clinical samples.